• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Doctors or mid-level providers for abortion.提供堕胎服务的医生或中级医疗人员。
Cochrane Database Syst Rev. 2015 Jul 27;2015(7):CD011242. doi: 10.1002/14651858.CD011242.pub2.
2
Surgical versus medical methods for second-trimester induced abortion.孕中期人工流产的手术方法与药物方法对比
Cochrane Database Syst Rev. 2025 Jul 8;7:CD006714. doi: 10.1002/14651858.CD006714.pub3.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Methods for managing miscarriage: a network meta-analysis.流产管理方法:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD012602. doi: 10.1002/14651858.CD012602.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Medical methods for first trimester abortion.医学方法终止早期妊娠。
Cochrane Database Syst Rev. 2022 May 24;5(5):CD002855. doi: 10.1002/14651858.CD002855.pub5.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
The use of telemedicine services for medical abortion.远程医疗服务在药物流产中的应用。
Cochrane Database Syst Rev. 2025 Jun 4;6(6):CD013764. doi: 10.1002/14651858.CD013764.pub2.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Abortion learning mechanisms for nurses and midwives: a scoping review of evidence.护士和助产士的堕胎学习机制:证据的范围综述
Sex Reprod Health Matters. 2025 Dec;33(1):2518672. doi: 10.1080/26410397.2025.2518672. Epub 2025 Aug 6.
2
Nurse practitioner medication abortion providers in Canada: results from a national survey.加拿大执业护士药物流产提供者:一项全国性调查的结果。
BMJ Sex Reprod Health. 2025 Apr 9;51(2):102-110. doi: 10.1136/bmjsrh-2024-202379.
3
Revolution in abortion care? Perspectives of key informants on the importance of abortion method choice in the era of telemedicine.堕胎护理的革命?关键知情人对远程医疗时代堕胎方法选择重要性的看法。
Sex Reprod Health Matters. 2023 Dec;31(1):2149379. doi: 10.1080/26410397.2022.2149379.
4
Barriers and enablers to nurse practitioner implementation of medication abortion in Canada: A qualitative study.在加拿大,护士从业者实施药物流产的障碍和促进因素:一项定性研究。
PLoS One. 2023 Jan 26;18(1):e0280757. doi: 10.1371/journal.pone.0280757. eCollection 2023.
5
Suspected illegal abortion and unsafe abortion leading to uterine rupture and incomplete abortion: A case report.疑似非法堕胎及不安全堕胎导致子宫破裂和不完全流产:一例病例报告。
Ann Med Surg (Lond). 2022 Nov 17;84:104933. doi: 10.1016/j.amsu.2022.104933. eCollection 2022 Dec.
6
Nurse practitioners on 'the leading edge' of medication abortion care: A feminist qualitative approach.处于药物流产护理“前沿”的执业护师:一种女性主义定性方法。
J Adv Nurs. 2023 Feb;79(2):686-697. doi: 10.1111/jan.15487. Epub 2022 Nov 11.
7
An empirical evaluation of the impact scenario of pooling bodies of evidence from randomized controlled trials and cohort studies in medical research.对医学研究中来自随机对照试验和队列研究的证据合并的影响场景的实证评估。
BMC Med. 2022 Oct 24;20(1):355. doi: 10.1186/s12916-022-02559-y.
8
Abortion services and providers in Canada in 2019: results of a national survey.2019 年加拿大的堕胎服务和提供者:全国调查结果。
CMAJ Open. 2022 Sep 27;10(3):E856-E864. doi: 10.9778/cmajo.20210232. Print 2022 Sep-Oct.
9
Medical methods for first trimester abortion.医学方法终止早期妊娠。
Cochrane Database Syst Rev. 2022 May 24;5(5):CD002855. doi: 10.1002/14651858.CD002855.pub5.
10
Evaluating agreement between bodies of evidence from randomized controlled trials and cohort studies in medical research: a meta-epidemiological study.评价医学研究中随机对照试验和队列研究证据体之间的一致性:一项meta 流行病学研究。
BMC Med. 2022 May 11;20(1):174. doi: 10.1186/s12916-022-02369-2.

本文引用的文献

1
The role of auxiliary nurse-midwives and community health volunteers in expanding access to medical abortion in rural Nepal.尼泊尔农村地区辅助护士-助产士及社区卫生志愿者在扩大药物流产可及性方面的作用。
Reprod Health Matters. 2015 Feb;22(44 Suppl 1):94-103. doi: 10.1016/S0968-8080(14)43784-4.
2
Physicians' and non-physicians' views about provision of medical abortion by nurses and AYUSH physicians in Maharashtra and Bihar, India.印度马哈拉施特拉邦和比哈尔邦医生与非医生对护士及阿育吠陀医生提供药物流产服务的看法。
Reprod Health Matters. 2015 Feb;22(44 Suppl 1):36-46. doi: 10.1016/S0968-8080(14)43787-X.
3
The efficacy, safety and acceptability of medical termination of pregnancy provided by standard care by doctors or by nurse-midwives: a randomised controlled equivalence trial.标准医护人员提供的医疗终止妊娠的效果、安全性和可接受性:一项随机对照等效试验。
BJOG. 2015 Mar;122(4):510-7. doi: 10.1111/1471-0528.12982. Epub 2014 Jul 18.
4
Safety of aspiration abortion performed by nurse practitioners, certified nurse midwives, and physician assistants under a California legal waiver.在加利福尼亚州的法律豁免下,由执业护士、认证护士助产士和医师助理进行吸引流产的安全性。
Am J Public Health. 2013 Mar;103(3):454-61. doi: 10.2105/AJPH.2012.301159. Epub 2013 Jan 17.
5
Safety and effectiveness of termination services performed by doctors versus midlevel providers: a systematic review and analysis.医生和中级医护人员实施终止妊娠服务的安全性和有效性:系统评价和分析。
Int J Womens Health. 2013;5:9-17. doi: 10.2147/IJWH.S39627. Epub 2013 Jan 4.
6
Feasibility of expanding the medication abortion provider base in India to include ayurvedic physicians and nurses.在印度扩大药物流产提供者基础,纳入阿育吠陀医师和护士的可行性。
Int Perspect Sex Reprod Health. 2012 Sep;38(3):133-42. doi: 10.1363/3813312.
7
Who can provide effective and safe termination of pregnancy care? A systematic review*.谁能提供有效且安全的终止妊娠护理?一项系统评价*。
BJOG. 2013 Jan;120(1):23-31. doi: 10.1111/j.1471-0528.2012.03464.x. Epub 2012 Aug 20.
8
Induced abortion: incidence and trends worldwide from 1995 to 2008.人工流产:1995 年至 2008 年全球发生率和趋势。
Lancet. 2012 Feb 18;379(9816):625-32. doi: 10.1016/S0140-6736(11)61786-8. Epub 2012 Jan 19.
9
Can nurses perform manual vacuum aspiration (MVA) as safely and effectively as physicians? Evidence from India.护士能否像医生一样安全有效地进行手动负压吸引术(MVA)?来自印度的证据。
Contraception. 2011 Dec;84(6):615-21. doi: 10.1016/j.contraception.2011.08.010. Epub 2011 Sep 28.
10
Medical methods for first trimester abortion.孕早期人工流产的医学方法。
Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD002855. doi: 10.1002/14651858.CD002855.pub4.

提供堕胎服务的医生或中级医疗人员。

Doctors or mid-level providers for abortion.

作者信息

Barnard Sharmani, Kim Caron, Park Min Hae, Ngo Thoai D

机构信息

Research Monitoring and Evaluation, Marie Stopes International, 1 Conway Street, 4 Fitzroy Square, London, UK, W1T 6LP.

出版信息

Cochrane Database Syst Rev. 2015 Jul 27;2015(7):CD011242. doi: 10.1002/14651858.CD011242.pub2.

DOI:10.1002/14651858.CD011242.pub2
PMID:26214844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9188302/
Abstract

BACKGROUND

The World Health Organization recommends that abortion can be provided at the lowest level of the healthcare system. Training mid-level providers, such as midwives, nurses and other non-physician providers, to conduct first trimester aspiration abortions and manage medical abortions has been proposed as a way to increase women's access to safe abortion procedures.

OBJECTIVES

To assess the safety and effectiveness of abortion procedures administered by mid-level providers compared to doctors.

SEARCH METHODS

We searched the CENTRAL Issue 7, MEDLINE and POPLINE databases for comparative studies of doctor and mid-level providers of abortion services. We searched for studies published in any language from January 1980 until 15 August 2014.

SELECTION CRITERIA

Randomised controlled trials (RCTs) (clustered or not clustered), prospective cohort studies or observational studies that compared the safety or effectiveness (or both) of any type of first trimester abortion procedure, administered by any type of mid-level provider or doctors, were eligible for inclusion in the review.

DATA COLLECTION AND ANALYSIS

Two independent review authors screened abstracts for eligibility and double-extracted data from the included studies using a pre-tested form. We meta-analysed primary outcome data using both fixed-effect and random-effects models to obtain pooled risk ratios (RR) with 95% confidence intervals (CIs). We carried out separate analyses by study design (RCT or cohort) and type of abortion procedure (medical versus surgical).

MAIN RESULTS

Eight studies involving 22,018 participants met our eligibility criteria. Five studies (n = 18,962) assessed the safety and effectiveness of surgical abortion procedures administered by mid-level providers compared to doctors. Three studies (n = 3056) assessed the safety and effectiveness of medical abortion procedures. The surgical abortion studies (one RCT and four cohort studies) were carried out in the United States, India, South Africa and Vietnam. The medical abortion studies (two RCTs and one cohort study) were carried out in India, Sweden and Nepal. The studies included women with gestational ages up to 14 weeks for surgical abortion and nine weeks for medical abortion.Risk of selection bias was considered to be low in the three RCTs, unclear in four observational studies and high in one observational study. Concealment bias was considered to be low in the three RCTs and high in all five observational studies. Although none of the eight studies performed blinding of the participants to the provider type, we considered the performance bias to be low as this is part of the intervention. Detection bias was considered to be high in all eight studies as none of the eight studies preformed blinding of the outcome assessment. Attrition bias was low in seven studies and high in one, with over 20% attrition. We considered six studies to have unclear risk of selective reporting bias as their protocols had not been published. The remaining two studies had published their protocols. Few other sources of bias were found.Based on an analysis of three cohort studies, the risk of surgical abortion failure was significantly higher when provided by mid-level providers than when procedures were administered by doctors (RR 2.25, 95% CI 1.38 to 3.68), however the quality of evidence for this outcome was deemed to be very low. For surgical abortion procedures, we found no significant differences in the risk of complications between mid-level providers and doctors (RR 0.99, 95% CI 0.17 to 5.70 from RCTs; RR 1.38, 95% CI 0.70 to 2.72 from observational studies). When we combined the data for failure and complications for surgical abortion we found no significant differences between mid-level providers and doctors in both the observational study analysis (RR 1.36, 95% CI 0.86 to 2.14) and the RCT analysis (RR 3.07, 95% CI 0.16 to 59.08). The quality of evidence of the outcome for RCT studies was considered to be low and for observational studies very low. For medical abortion procedures the risk of failure was not different for mid-level providers or doctors (RR 0.81, 95% CI 0.48 to 1.36 from RCTs; RR 1.09, 95% CI 0.63 to 1.88 from observational studies). The quality of evidence of this outcome for the RCT analysis was considered to be high, although the quality of evidence of the observational studies was considered to be very low. There were no complications reported in the three medical abortion studies.

AUTHORS' CONCLUSIONS: There was no statistically significant difference in the risk of failure for medical abortions performed by mid-level providers compared with doctors. Observational data indicate that there may be a higher risk of abortion failure for surgical abortion procedures administered by mid-level providers, but the number of studies is small and more robust data from controlled trials are needed. There were no statistically significant differences in the risk of complications for first trimester surgical abortions performed by mid-level providers compared with doctors.

摘要

背景

世界卫生组织建议,可在医疗保健系统的最低级别提供堕胎服务。有人提议培训中级医疗服务提供者,如助产士、护士和其他非医生医疗服务提供者,使其能够实施孕早期负压吸宫流产手术并管理药物流产,以此增加妇女获得安全堕胎程序的机会。

目的

评估与医生相比,中级医疗服务提供者实施堕胎手术的安全性和有效性。

检索方法

我们检索了Cochrane系统评价数据库第7期、医学期刊数据库和人口与健康数据库,以查找有关医生和中级堕胎服务提供者的比较研究。我们检索了1980年1月至2014年8月15日期间以任何语言发表的研究。

入选标准

随机对照试验(RCTs)(聚类或非聚类)、前瞻性队列研究或观察性研究,比较了由任何类型的中级医疗服务提供者或医生实施的任何类型孕早期堕胎手术的安全性或有效性(或两者),均符合纳入本综述的条件。

数据收集与分析

两名独立的综述作者筛选摘要以确定其是否符合条件,并使用预先测试的表格从纳入研究中双重提取数据。我们使用固定效应模型和随机效应模型对主要结局数据进行荟萃分析,以获得合并风险比(RR)及95%置信区间(CIs)。我们按研究设计(RCT或队列)和堕胎手术类型(药物流产与手术流产)进行了单独分析。

主要结果

八项研究涉及22,018名参与者,符合我们的入选标准。五项研究(n = 18,962)评估了与医生相比,中级医疗服务提供者实施手术流产手术的安全性和有效性。三项研究(n = 3056)评估了药物流产的安全性和有效性。手术流产研究(一项RCT和四项队列研究)在美国、印度、南非和越南进行。药物流产研究(两项RCT和一项队列研究)在印度、瑞典和尼泊尔进行。这些研究纳入了孕龄长达14周的手术流产妇女和孕龄长达9周的药物流产妇女。三项RCT的选择偏倚风险被认为较低,四项观察性研究的选择偏倚风险不明确,一项观察性研究的选择偏倚风险较高。三项RCT的隐蔽偏倚被认为较低,所有五项观察性研究的隐蔽偏倚被认为较高。尽管八项研究中没有一项对参与者隐瞒提供者类型,但我们认为执行偏倚较低,因为这是干预措施的一部分。八项研究中的所有研究均被认为检测偏倚较高,因为八项研究中没有一项对结局评估进行盲法处理。七项研究的失访偏倚较低,一项研究的失访偏倚较高,失访率超过20%。我们认为六项研究的选择性报告偏倚风险不明确,因为它们的研究方案未发表。其余两项研究发表了其研究方案。几乎未发现其他偏倚来源。基于三项队列研究的分析,中级医疗服务提供者实施手术流产失败的风险显著高于医生实施手术流产的风险(RR 2.25,95%CI 1.38至3.68),然而该结局的证据质量被认为非常低。对于手术流产手术,我们发现中级医疗服务提供者和医生之间并发症风险没有显著差异(来自RCT的RR 0.99,95%CI 0.17至5.70;来自观察性研究的RR 1.38,95%CI 0.70至2.72)。当我们合并手术流产失败和并发症的数据时,我们发现在观察性研究分析(RR 1.36,95%CI 0.86至2.14)和RCT分析(RR 3.07,95%CI 0.16至59.08)中,中级医疗服务提供者和医生之间均无显著差异。RCT研究结局的证据质量被认为较低,观察性研究结局的证据质量被认为非常低。对于药物流产手术,中级医疗服务提供者和医生的失败风险没有差异(来自RCT的RR 0.81,95%CI 0.48至1.36;来自观察性研究的RR 1.09,95%CI 0.63至1.88)。RCT分析该结局的证据质量被认为较高,尽管观察性研究的证据质量被认为非常低。三项药物流产研究均未报告并发症。

作者结论

与医生相比,中级医疗服务提供者实施药物流产的失败风险无统计学显著差异。观察性数据表明,中级医疗服务提供者实施手术流产手术的失败风险可能更高,但研究数量较少,需要来自对照试验的更有力数据。与医生相比,中级医疗服务提供者实施孕早期手术流产的并发症风险无统计学显著差异。